DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Brandes AA, Carpentier AF, Kesari S. , et al.
A phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.
Neuro Oncol 2016;
18 (08) 1146-1156
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.